Beijing, China

Hesheng Luo




Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hesheng Luo: Innovator in Medicinal Compositions

Introduction

Hesheng Luo is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal compositions, particularly through his innovative patent related to ginseng secondary glycosides. His work has implications for treating various cardiovascular conditions.

Latest Patents

Hesheng Luo holds a patent for a medicinal composition containing ginseng secondary glycosides, its preparation method, and application. The composition primarily includes ginsenoside Rg3 and ginsenoside Rg2, along with ginsenoside Rh1 as active ingredients. This composition is prepared from ginseng plants through a process of extraction, acid hydrolysis, and purification using macroreticular resin. It is particularly useful in the manufacture of medicaments for treating conditions such as coronary heart disease (CHD), angina pectoris, myocardial ischemia, hemorrhagic shock, heart failure, and arrhythmia. He has 1 patent to his name.

Career Highlights

Throughout his career, Hesheng Luo has worked with various organizations, including the National Institute of Pharmaceutical R&D Co., Ltd. and Shanghai Hongyitang Biopharmaceutical Technology Co., Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of effective medicinal solutions.

Collaborations

Hesheng Luo has collaborated with notable colleagues such as Congxin Sun and Yongli Zhao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical field.

Conclusion

Hesheng Luo's innovative contributions to medicinal compositions highlight the importance of research in developing effective treatments for cardiovascular diseases. His work continues to influence the pharmaceutical industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…